GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
6C5K | 6C5K | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2) | |
6C5K | A0A0F7R5U8 | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2) | |
6C5K | A0A0F7R5U8 | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2) | |
6C5H | 6C5H | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C5H | Q99LC4 | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C5H | 6C5H | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C5H | Q99LC4 | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C5H | A0A0F7R5U8 | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C5H | A0A0F7R5U8 | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
4JCF | P03089 | S268F Variant of JC Polyomavirus Major Capsid Protein VP1 in Complex with LSTc | |
1Q9W | 1Q9W | S45-18 Fab pentasaccharide bisphosphate complex | |
8D0Z | P0DTC2 | S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) | |
8D0Z | 8D0Z | S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) | |
6KYW | Q39276 | S8-mSRK-S8-SP11 complex | Receptor protein kinase SRK8, S locus protein 11 |
6KYW | Q9SE17 | S8-mSRK-S8-SP11 complex | Receptor protein kinase SRK8, S locus protein 11 |
5FIH | N1P1N2 | SACCHAROMYCES CEREVISIAE GAS2P (E176Q MUTANT) IN COMPLEX WITH LAMINARITETRAOSE AND LAMINARIPENTAOSE | |
2W63 | Q06135 | SACCHAROMYCES CEREVISIAE GAS2P IN COMPLEX WITH LAMINARITRIOSE AND LAMINARITETRAOSE | |
7TJQ | 7TJQ | SAN27-14 bound to a antigenic site V on prefusion-stabilized hMPV F | |
7TJQ | H6X1Z0 | SAN27-14 bound to a antigenic site V on prefusion-stabilized hMPV F | |
1HSJ | P0AEY0 | SARR MBP FUSION STRUCTURE | |
1HSJ | Q2YYV0 | SARR MBP FUSION STRUCTURE | |
7ZH2 | P59594 | SARS CoV Spike protein, Closed C1 conformation | |
7ZH2 | P10104 | SARS CoV Spike protein, Closed C1 conformation | |
7ZH1 | P59594 | SARS CoV Spike protein, Closed C3 conformation | |
7ZH1 | P10104 | SARS CoV Spike protein, Closed C3 conformation | |
7ZH5 | P59594 | SARS CoV Spike protein, Open conformation | |
7ZH5 | P10104 | SARS CoV Spike protein, Open conformation | |
7ODL | P0DTC2 | SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C1 symmetry | |
7OD3 | P0DTC2 | SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry | |
6ZB4 | P0DTC2 | SARS CoV-2 Spike protein, Closed conformation, C1 symmetry | Spike glycoprotein |
6ZB5 | P0DTC2 | SARS CoV-2 Spike protein, Closed conformation, C3 symmetry | Spike glycoprotein |
8A94 | P0DTC2 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A94 | 8A94 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A94 | P0DTC2 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
8A94 | 8A94 | SARS CoV2 Spike in the 2-up state in complex with Fab47. | |
7MPB | P0DTD1 | SARS Coronavirus-2 Main Protease 3CL-pro binding Ascorbate | |
8A95 | P0DTC2 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | 8A95 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | P0DTC2 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A95 | 8A95 | SARS Cov2 Spike RBD in complex with Fab47 | |
8A99 | P0DTC2 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | 8A99 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | P0DTC2 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
8A99 | 8A99 | SARS Cov2 Spike in 1-up conformation complex with Fab47 | |
6CS2 | P59594 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | D9IEJ2 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | Q9BYF1 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CRV | P59594 | SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRV | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRW | P59594 | SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation | Spike glycoprotein,Envelope glycoprotein |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024